Clinical Trials in New York

Showing 15701-15720 of 22,668 trials

Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab

NCT01223235

The immune system of the body has the ability to fight and eliminate infections and cancers. Immune treatments, such as in this study, seek to teach the immune system to find and destroy cancer cells. The purpose of this study is to test whether it is safe to treat the cancer with a vaccine and another drug called bevacizumab (also known as Avastin).

Fallopian Tubes CancerOvarian CancerPeritoneal Cancer

Memorial Sloan Kettering Cancer Center22 participantsStarted Oct 2010

New York, New York, United States

COMPLETEDPhase 3< 1 mile

A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation

NCT02392234

The purpose of this study is to evaluate the efficacy and safety of VX-661 in combination with ivacaftor (IVA, VX-770) and IVA monotherapy in participants with Cystic Fibrosis (CF) who are heterozygous for F508del-CFTR allele and a second allele with a CFTR mutation predicted to have residual function.

Cystic Fibrosis

Vertex Pharmaceuticals Incorporated248 participantsStarted Mar 2015

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +90 more locations

Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab

A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation

Find Trials by Condition in New York

A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation

Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission

Exercise and Inflammation

Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy

Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma

Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma

Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus

An Open Label Study for Participants With Rheumatoid Arthritis

Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia

Group Clinical Visit Adherence Intervention for HIV+ Women of Color

Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older

Bioequivalence Study on Vitamin D in Healthy Adults

Clinical Study on the Bioequivalence of Vitamin D in Healthy Adults

Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults

A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Myotubular Myopathy (MTM)

A Study of Tasisulam in Treating Participants With Malignant Melanoma

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older